1. Home
  2. BMEA vs RANG Comparison

BMEA vs RANG Comparison

Compare BMEA & RANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • RANG
  • Stock Information
  • Founded
  • BMEA 2017
  • RANG 2024
  • Country
  • BMEA United States
  • RANG United States
  • Employees
  • BMEA N/A
  • RANG N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • RANG
  • Sector
  • BMEA Health Care
  • RANG
  • Exchange
  • BMEA Nasdaq
  • RANG Nasdaq
  • Market Cap
  • BMEA 145.0M
  • RANG 159.6M
  • IPO Year
  • BMEA 2021
  • RANG 2024
  • Fundamental
  • Price
  • BMEA $3.46
  • RANG $10.01
  • Analyst Decision
  • BMEA Buy
  • RANG
  • Analyst Count
  • BMEA 13
  • RANG 0
  • Target Price
  • BMEA $27.92
  • RANG N/A
  • AVG Volume (30 Days)
  • BMEA 414.8K
  • RANG 15.6K
  • Earning Date
  • BMEA 03-31-2025
  • RANG 01-01-0001
  • Dividend Yield
  • BMEA N/A
  • RANG N/A
  • EPS Growth
  • BMEA N/A
  • RANG N/A
  • EPS
  • BMEA N/A
  • RANG N/A
  • Revenue
  • BMEA N/A
  • RANG N/A
  • Revenue This Year
  • BMEA N/A
  • RANG N/A
  • Revenue Next Year
  • BMEA N/A
  • RANG N/A
  • P/E Ratio
  • BMEA N/A
  • RANG N/A
  • Revenue Growth
  • BMEA N/A
  • RANG N/A
  • 52 Week Low
  • BMEA $3.25
  • RANG $9.91
  • 52 Week High
  • BMEA $19.36
  • RANG $10.64
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 34.96
  • RANG N/A
  • Support Level
  • BMEA $3.25
  • RANG N/A
  • Resistance Level
  • BMEA $3.75
  • RANG N/A
  • Average True Range (ATR)
  • BMEA 0.24
  • RANG 0.00
  • MACD
  • BMEA 0.00
  • RANG 0.00
  • Stochastic Oscillator
  • BMEA 21.43
  • RANG 0.00

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About RANG Range Capital Acquisition Corp. Ordinary Shares

Range Capital Acquisition Corp is a blank check company.

Share on Social Networks: